|
|
||||||||
J Thorac Cardiovasc Surg 1996;111:545-553
© 1996 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
Received for publication Feb. 3, 1995 Accepted for publication May 23, 1995. Address for reprints: Marie-Christine Seghaye, MD, Department of Pediatric Cardiology, RWTH Aachen, Pauwelsstrasse D, 52057 Aachen, Germany.
Abstract
To evaluate cytokine balance related to cardiopulmonary bypass, we prospectively investigated 11 infants undergoing cardiac operations for congenital heart disease. Proinflammatory cytokines (tumor necrosis factor-
and interleukin-8) and the antiinflammatory cytokine interleukin-10 were measured at multiple time points before, during, and after bypass. Tumor necrosis factor-
and interleukin-8 values were within normal range before the operation. These values increased significantly during bypass, reaching their peaks after protamine administration (tumor necrosis factor-
, 133.6 ± 124.9 pg/ml; mean ± standard deviation; p < 0.005) and 2 hours after termination of the procedure (interleukin-8, 92.1 ± 44.1 pg/ml; p < 0.01). Tumor necrosis factor-
and interleukin-8 equaled normal prebypass values from the first postoperative day on. Interleukin-10 levels were within normal range before the operation and were already significantly increased 10 minutes after initiation of bypass (interleukin-10, 39.4 ± 34.3 pg/ml; p < 0.05). These levels remained elevated throughout the procedure but returned to normal after protamine administration. A second significant release of interleukin-10 occurred from the early postoperative period on, reaching its peak 24 hours after termination of cardiopulmonary bypass (interleukin-10, 351.6 ± 304.0 pg/ml; p < 0.01). Interleukin-10 values were normal on the second postoperative day in all patients. Interleukin-10 kinetics showed an inverse pattern compared with tumor necrosis factor-
and interleukin-8. This difference suggests an interplay between proinflammatory and antiinflammatory cytokines released during and after cardiopulmonary bypass. Interleukin-10 levels measured 4 and 24 hours after bypass strongly correlated with the degree of hypothermia during bypass (Spearman's correlation coefficient, -0.77 [p < 0.01] and -0.89 [p < 0.0005], respectively); these levels did not correlate with duration of bypass and aortic crossclamping, however. This result suggests that besides immunologically mediated production of interleukin-10, hypothermia itself could modulate interleukin-10 production. In conclusion, this study demonstrates interleukin-10 production, in addition to interleukin-8 and tumor necrosis factor-
synthesis, in response to cardiopulmonary bypass in infants. Interleukin-10 could play a protective role by down-regulating proinflammatory cytokine release during and after cardiopulmonary bypass. (J THORACCARDIOVASCSURG1996;111:545-53)
This article has been cited by other articles:
![]() |
E Hirleman and D. Larson Cardiopulmonary bypass and edema: physiology and pathophysiology Perfusion, November 1, 2008; 23(6): 311 - 322. [Abstract] [PDF] |
||||
![]() |
J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text] |
||||
![]() |
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text] |
||||
![]() |
H. H. Hovels-Gurich, J. F. Vazquez-Jimenez, A. Silvestri, K. Schumacher, R. Minkenberg, J. Duchateau, B. J. Messmer, G. von Bernuth, and M.-C. Seghaye Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 811 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Borgermann, I. Friedrich, S. Flohe, J. Spillner, M. Majetschak, O. Kuss, A. Sablotzki, T. Feldt, J. C. Reidemeister, and F. U. Schade Tumor necrosis factor-{alpha} production in whole blood after cardiopulmonary bypass: Downregulation caused by circulating cytokine-inhibitory activities J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 608 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alcaraz, L. Sancho, L. Manzano, F. Esquivel, A. Carrillo, A. Prieto, E. D. Bernstein, and M. Alvarez-Mon Newborn patients exhibit an unusual pattern of interleukin 10 and interferon {gamma} serum levels in response to cardiac surgery J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Hovels-Gurich, K. Schumacher, J. F. Vazquez-Jimenez, M. Qing, U. Huffmeier, B. Buding, B. J. Messmer, G. von Bernuth, and M.-C. Seghaye Cytokine balance in infants undergoing cardiac operation Ann. Thorac. Surg., February 1, 2002; 73(2): 601 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Vazquez-Jimenez, M. Qing, B. Hermanns, B. Klosterhalfen, M. Woltje, R. Chakupurakal, K. Schumacher, B. J. Messmer, G.o. von Bernuth, and M.-C. Seghaye Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF] |
||||
![]() |
D. A. Smith, S. D. Irving, J. Sheldon, D. Cole, and J. C. Kaski Serum Levels of the Antiinflammatory Cytokine Interleukin-10 Are Decreased in Patients With Unstable Angina Circulation, August 14, 2001; 104(7): 746 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Flohe, J. Borgermann, L. Lim, and F.-U. Schade Interferon-{gamma} counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass Innate Immunity, December 1, 2000; 6(6): 431 - 436. [Abstract] [PDF] |
||||
![]() |
P. Corbi, M. Rahmati, A. Delwail, D. Potreau, P. Menu, J. Wijdenes, and J.-C. Lecron Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 98 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, B. Zingarelli, and C. Szabo Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury Circulation, March 7, 2000; 101(9): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Gilliland, M. A. Armstrong, and T. J. McMurray The Inflammatory Response to Pediatric Cardiac Surgery: Correlation of Granulocyte Adhesion Molecule Expression with Postoperative Oxygenation Anesth. Analg., November 1, 1999; 89(5): 1188 - 1188. [Full Text] [PDF] |
||||
![]() |
A. Tarnok, J. Hambsch, and P. Schneider Cardiopulmonary bypass-induced increase of serum interleukin-10levels in children J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 475 - 477. [Full Text] [PDF] |
||||
![]() |
G. E. Hill, R. P. Diego BS, A. H. Stammers, S. M. Huffman, and R. Pohorecki Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Ann. Thorac. Surg., January 1, 1998; 65(1): 66 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wan, J.-L. LeClerc, and J.-L. Vincent Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276. [Abstract] [Full Text] |
||||
![]() |
T. Sugita, S. Watarida, K. Katsuyama, Y. Nakajima, R. Yamamoto, and A. Mori Interleukin-10 concentration in children undergoing cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1127 - 1127. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |